Stock listing
HKEX:2186 Luye Pharma Group Ltd. (綠葉製藥) 股價
Home listing (HKEX) of Luye Pharma Group Ltd.
Follow Luye Pharma Group Ltd. into a list and get an email when it puts out news.
Share price · HKEX:2186
$1.69 HKD -0.02 (-1.2%)
Close on Oct 20, 2026
- Day range
- $1.68 – $1.72 HKDOct 20, 2026
- Volume
- 19.74M sharesOct 20, 2026
- 52-week range
- $1.66 – $3.30 HKDLowest and highest trades, Oct 21, 2025 – Oct 20, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| HKEX:2186 · Home | $1.685 HKD | -0.02 (-1.2%) | 19,741,500 | $1.705 | $1.715 | $1.675 | $1.705 | Close on Oct 20, 2026 |
| Frankfurt:LUP | €0.189 EUR | -0.002 (-1.0%) | — | €0.189 | €0.189 | €0.189 | €0.191 | Close on Oct 20, 2026 |
Daily closes
Last 3 months, Jul 20, 2026 – Oct 20, 2026 · HKEX:2186 · HKD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.685 | -0.02 | -1.2% | $1.705 | $1.715 | $1.675 | 19,741,500 | |
| $1.705 | -0.015 | -0.9% | $1.72 | $1.755 | $1.685 | 30,872,002 | |
| $1.72 | +0.02 | +1.2% | $1.70 | $1.72 | $1.67 | 20,816,000 | |
| $1.70 | -0.01 | -0.6% | $1.72 | $1.72 | $1.68 | 11,492,798 | |
| $1.71 | -0.01 | -0.6% | $1.72 | $1.72 | $1.655 | 25,305,500 | |
| $1.72 | -0.01 | -0.6% | $1.745 | $1.755 | $1.705 | 14,568,000 | |
| $1.73 | -0.035 | -2.0% | $1.775 | $1.78 | $1.725 | 29,590,500 | |
| $1.765 | -0.025 | -1.4% | $1.835 | $1.855 | $1.765 | 31,632,000 | |
| $1.79 | -0.05 | -2.7% | $1.865 | $1.865 | $1.785 | 3,510,000 | |
| $1.84 | +0.035 | +1.9% | $1.815 | $1.845 | $1.815 | 2,134,000 | |
| $1.805 | -0.025 | -1.4% | $1.72 | $1.82 | $1.72 | 2,481,000 | |
| $1.83 | -0.065 | -3.4% | $1.89 | $1.89 | $1.78 | 8,243,000 | |
| $1.895 | +0.07 | +3.8% | $1.815 | $1.895 | $1.815 | 23,191,000 | |
| $1.825 | +0.04 | +2.2% | $1.795 | $1.835 | $1.785 | 16,376,000 | |
| $1.785 | -0.05 | -2.7% | $1.86 | $1.905 | $1.77 | 35,568,000 | |
| $1.835 | -0.05 | -2.7% | $1.89 | $1.90 | $1.82 | 2,611,500 | |
| $1.885 | -0.025 | -1.3% | $1.91 | $1.945 | $1.865 | 24,507,500 | |
| $1.91 | +0.07 | +3.8% | $1.845 | $1.92 | $1.825 | 32,407,500 | |
| $1.84 | -0.035 | -1.9% | $1.88 | $1.88 | $1.815 | 27,272,000 | |
| $1.875 | +0.125 | +7.1% | $1.775 | $1.925 | $1.755 | 81,285,922 | |
| $1.75 | +0.05 | +2.9% | $1.72 | $1.77 | $1.705 | 46,735,855 | |
| $1.70 | -0.065 | -3.7% | $1.76 | $1.76 | $1.69 | 52,330,473 | |
| $1.765 | -0.03 | -1.7% | $1.795 | $1.795 | $1.745 | 34,259,500 | |
| $1.795 | +0.005 | +0.3% | $1.79 | $1.81 | $1.77 | 11,242,000 | |
| $1.79 | -0.01 | -0.6% | $1.79 | $1.83 | $1.77 | 20,816,000 | |
| $1.80 | -0.03 | -1.6% | $1.82 | $1.82 | $1.79 | 16,109,500 | |
| $1.83 | -0.035 | -1.9% | $1.86 | $1.86 | $1.80 | 29,025,500 | |
| $1.865 | -0.055 | -2.9% | $1.915 | $1.915 | $1.85 | 23,020,000 | |
| $1.92 | +0.035 | +1.9% | $1.89 | $1.925 | $1.865 | 14,177,500 | |
| $1.885 | -0.01 | -0.5% | $1.89 | $1.905 | $1.855 | 24,612,000 | |
| $1.895 | +0.02 | +1.1% | $1.895 | $1.91 | $1.865 | 18,418,500 | |
| $1.875 | +0.03 | +1.6% | $1.845 | $1.90 | $1.845 | 26,557,500 | |
| $1.845 | -0.055 | -2.9% | $1.90 | $1.91 | $1.835 | 29,449,500 | |
| $1.90 | -0.04 | -2.1% | $1.94 | $1.95 | $1.88 | 42,259,500 | |
| $1.94 | -0.19 | -8.9% | $2.125 | $2.125 | $1.875 | 104,662,000 | |
| $2.13 | -0.015 | -0.7% | $2.145 | $2.195 | $2.095 | 34,007,500 | |
| $2.145 | -0.025 | -1.2% | $2.17 | $2.22 | $2.085 | 64,106,000 | |
| $2.17 | +0.02 | +0.9% | $2.17 | $2.23 | $2.155 | 30,129,639 | |
| $2.15 | +0.045 | +2.1% | $2.105 | $2.185 | $2.095 | 18,779,500 | |
| $2.105 | -0.055 | -2.5% | $2.17 | $2.17 | $2.09 | 28,617,500 | |
| $2.16 | +0.015 | +0.7% | $2.21 | $2.315 | $2.15 | 88,265,508 | |
| $2.145 | +0.155 | +7.8% | $2.04 | $2.185 | $2.03 | 100,124,031 | |
| $1.99 | -0.03 | -1.5% | $2.02 | $2.02 | $1.975 | 18,853,148 | |
| $2.02 | -0.03 | -1.5% | $2.065 | $2.07 | $2.005 | 19,472,479 | |
| $2.05 | 0.00 | 0.0% | $2.045 | $2.08 | $2.015 | 16,300,000 | |
| $2.05 | -0.065 | -3.1% | $2.115 | $2.115 | $2.03 | 21,045,000 | |
| $2.115 | +0.01 | +0.5% | $2.095 | $2.18 | $2.09 | 27,415,000 | |
| $2.105 | +0.005 | +0.2% | $2.125 | $2.125 | $2.075 | 11,448,000 | |
| $2.10 | -0.015 | -0.7% | $2.12 | $2.16 | $2.09 | 25,210,000 | |
| $2.115 | -0.015 | -0.7% | $2.175 | $2.195 | $2.10 | 28,980,000 | |
| $2.13 | +0.065 | +3.1% | $2.065 | $2.145 | $2.055 | 47,226,883 | |
| $2.065 | 0.00 | 0.0% | $2.10 | $2.115 | $2.06 | 18,050,736 | |
| $2.065 | +0.02 | +1.0% | $2.05 | $2.075 | $2.03 | 14,920,000 | |
| $2.045 | -0.01 | -0.5% | $2.055 | $2.11 | $2.02 | 21,278,500 | |
| $2.055 | +0.025 | +1.2% | $2.04 | $2.065 | $2.03 | 10,268,488 | |
| $2.03 | +0.01 | +0.5% | $2.03 | $2.07 | $2.00 | 18,501,500 | |
| $2.02 | -0.08 | -3.8% | $2.12 | $2.13 | $2.01 | 38,629,000 | |
| $2.10 | 0.00 | 0.0% | $2.10 | $2.15 | $2.09 | 24,606,500 | |
| $2.10 | +0.05 | +2.4% | $2.06 | $2.11 | $2.04 | 22,631,500 | |
| $2.05 | -0.03 | -1.4% | $2.09 | $2.10 | $2.05 | 25,333,500 | |
| $2.08 | -0.04 | -1.9% | $2.10 | $2.14 | $2.07 | 15,829,500 | |
| $2.12 | +0.01 | +0.5% | $2.11 | $2.14 | $2.08 | 22,416,859 | |
| $2.11 | -0.07 | -3.2% | $2.18 | $2.21 | $2.10 | 35,478,000 | |
| $2.18 | +0.03 | +1.4% | $2.16 | $2.19 | $2.08 | 31,135,000 | |
| $2.15 | +0.09 | +4.4% | $2.07 | $2.16 | $2.07 | 44,034,500 |
- Ticker
- HKEX:2186
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- HKEX
- Currency
- HKD
What changed lately
Latest news release · Oct 7, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Latest news
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Oct 7, 2026
Closed $1.77 (-1.4%) on Oct 8, 2026
Interim Report 2026
Sep 29, 2026
Closed $1.90 (+3.8%) on Sep 30, 2026
Luye Pharma Announces 2026 Interim Results
Sep 1, 2026
Closed $1.85 (-2.9%) on Sep 2, 2026
Luye Pharma Announces Successful Completion of a U.S. Bridging Clinical Trial of Its Innovative Drug LY03015 (VMAT2 Inhibitor/Sigma-1R...
Aug 5, 2026
Closed $2.07 (0.0%) on Aug 6, 2026
Luye Pharma Announces Positive Phase 2 Results of LY03015, a VMAT2 Inhibitor and Sigma-1R Agonist, for Tardive Dyskinesia in China
Jun 16, 2026
Closed $1.97 (+7.7%) on Jun 17, 2026
Luye Pharma Announces First Subject Enrolled in U.S. PK Bridging Clinical Trial of Its VMAT2 Inhibitor/Sigma-1R Agonist LY03015
Apr 21, 2026
Closed $2.82 (0.0%) on Apr 21, 2026
First Subject Enrolled in Phase Ⅱ Clinical Trial of Luye Pharma’s TAAR1/5-HT2CR-targeted Investigational Drug for Treating...
Apr 8, 2026
Closed $2.84 (-1.0%) on Apr 9, 2026
NMPA Accepts the NDA for Luye Pharma’s Ruoxinlin® for the New Indication of Generalized Anxiety Disorder
Jan 8, 2026
Closed $3.02 (+2.4%) on Jan 9, 2026
Luye Pharma Receives FDA Clearance of IND Application for Its Next-generation 5-HT2AR Inverse Agonist/5-HT2CR Antagonist LY03017
Nov 24, 2025
Closed $3.01 (+1.7%) on Nov 24, 2025
Luye Pharma Group Ltd. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 9 in the last 12 months · 31 in all · newest Oct 7, 2026 · oldest 2023
Where Luye Pharma Group Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| HKEX:2186 綠葉製藥 · Home listing · This page | HKEX | Hong Kong | HKD |
| OTC:LYPHF | OTC | United States | USD |
| gettex:LUP | gettex | Germany | EUR |
| LS Exchange:A116Z9 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A116Z9 | Lang & Schwarz | Germany | EUR |
| Frankfurt:LUP | Frankfurt | Germany | EUR |
| Dusseldorf:LUP | Dusseldorf | Germany | EUR |
| Munich:LUP | Munich | Germany | EUR |
| Stuttgart:LUP | Stuttgart | Germany | EUR |
Log in to ask 6ix AI your own questions about Luye Pharma Group Ltd.